The Power—or Threat—of Vertical Integration in Healthcare

Posted by Jacob Golbitz on Apr 10, 2018 5:24:25 PM

How CVS Health’s Performance Based Pharmacy Network Demonstrates its Competitive Strategy

In March 2018, CVS Health has introduced a ‘performance based pharmacy network,’ comprised of 30,000 CVS and Walgreens and approximately 10,000 other retail pharmacies nationwide. Mirroring the value-based model to incentivize pharmacies to help patients adhere to prescription regimens, the new network has the potential to control costs and improve the quality of care through increased access and convenience. In addition to addressing some of healthcare’s most pressing challenges, CVS Heath’s activities highlight how vertical integration is securing its market position and demonstrates how this strategy could be threatening to payers.

Read More

Topics: New Market Entry, Healthcare, Merger and Acquisition, Insurers

Walmart’s Potential Acquisition of Humana: Competitive Strategy Implications for the U.S. Healthcare Industry

Posted by Ken Sawka on Mar 30, 2018 1:28:34 PM

 

I loathe the pervasive, trite metaphor that compares competitive strategy to the game of chess.  However, recent reports that Walmart is in discussions to acquire health insurer Humana can only be explained as a game of three-dimensional chess.  Should this deal go through – and, to be sure, it is a long way from happening – it satisfies three competitive strategy objectives for Walmart: responding to CVS Health, blocking Amazon and improving access to new customer segments.

Read More

Topics: Competitive Intelligence, Healthcare, Merger and Acquisition, Competitive Strategy

What are the Competitive Strategy Implications of Uber's European Regulatory Woes?

Posted by Ken Sawka on Jan 10, 2018 10:44:04 PM

Let me be clear right from the start – I loathe Uber. While I’m a big fan of ride-hailing services, I simply can’t give my business to a company that harasses its employees, whose CEO berates its drivers, uses questionable means to skirt regulation, and allegedly steals trade secrets from its competitors. I’m a Lyft guy through and through.

Read More

Topics: Brand Insights, Industry Convergence, Merger and Acquisition, Competitive Strategy, Early Warning

WeWork, Lord & Taylor, and the Artificial Separation of Work and Leisure

Posted by Ken Sawka on Nov 21, 2017 4:18:48 PM

One of my fondest memories growing up in New York was going into “the city” (that’s what we Long Islanders called Manhattan) at Christmastime and going to see the Lord & Taylor Christmas display in its storefront window at its flagship location on Fifth Avenue.  There would be long lines, and we’d wait 20 minutes or more just to get a glimpse of the window.  It was magical.

Read More

Topics: Sales Force Effectiveness, Brand Insights, Market Analysis, Merger and Acquisition, Product Positioning

Managing Regulatory and Political Risk

Posted by Robert Flynn on Nov 21, 2017 3:38:26 PM

In our paper The Global Economy’s New Frontiers, my colleague Nathaniel Emmons and I argue that when investing in emerging economies, companies can realize high returns but only if the risks are successfully managed. Transnational mining companies operating in Zimbabwe, for instance, are in crisis management mode following this month’s coup, impeachment of President Mugabe, and transfer of power to yet another strong-man. Not an unanticipated series of events given the political instability experienced in recent years, and something that needs intense effort to navigate.

Read More

Topics: Consumer Goods, Healthcare, Merger and Acquisition, Competitive Strategy, Early Warning

Six Reasons Why CVS Health Should Acquire Aetna … Soon

Posted by Robert Flynn on Jun 21, 2017 10:00:00 AM

Should CVS consider acquiring a health plan? If yes, then which one? With a market-cap of about $80 billion and an impressive portfolio of assets across retail and pharmacy, why would it make sense for CVS to include a health plan in its portfolio?

Read More

Topics: Brand Insights, Healthcare, Merger and Acquisition, Competitive Strategy

Developing R&D Strategy for Industrial Goods

Posted by Fuld + Company on Mar 31, 2016 4:48:40 PM

For companies developing an R&D strategy in industrial goods and infrastructure, competitive intelligence provides unique insights into competitors’ existing and potential R&D interest, capabilities, technology bets, and expected outcomes. Comparing rival R&D strategies to market needs and expectations provides a reality check on the feasibility and potential value of your future R&D programs. 

Strategic planning integrated with competitive and market intelligence can:

Read More

Topics: Competitive Intelligence, Product Roadmap, Fuld + Company, Manufacturing/Industrial, Market Analysis, Merger and Acquisition, Competitive Strategy

Five Things Lockheed Martin Needs Sikorsky to Do

Posted by Christopher Dent on Dec 3, 2015 8:00:00 AM

On November 6th, United Technologies Corporation (UTC) closed the sale of its Sikorsky aerospace unit to defense giant Lockheed Martin for $9B.  Does this acquisition improve the strategic position of both companies or will Sikorsky prove to be a white elephant?

Read More

Topics: Brand Insights, Market Analysis, Merger and Acquisition, Competitive Strategy

Dell Acquires EMC: Heavy Clouds, No Rain

Posted by Ken Sawka on Oct 27, 2015 12:06:53 PM


On October 12, Dell announced its plans to acquire EMC Corporation for $67 billion
, the largest technology industry deal to date, a deal clearly intended to bolster Dell’s ability to compete in the increasingly lucrative corporate data center market. This move follows HP’s split into two organizations which itself was engineered to free HP’s enterprise business from the low-margin shackles of its consumer PC and printer business.  While the Dell-EMC deal will accelerate the transition of corporate data assets to the cloud, the new entity could face significant challenges that hamper its ability to make it rain. 

Our experience conducting war games for Global Fortune 100 companies and analyzing competition in enterprise IT has made it clear that the market is undergoing a dramatic transformation. Our analysis, conducted over an extensive period of time and involving a variety of players, demonstrates that this transformation is characterized by several confluent factors that the combined EMC-Dell will have to navigate to achieve success: 

Read More

Topics: Competitive Intelligence, War Games, Brand Insights, Market Analysis, Technology/Telecomm, Merger and Acquisition

Jack Bauer and the Flu

Posted by Robert Flynn on Oct 23, 2015 6:49:12 AM

On February 5, 2015, Public Health England announced that the flu vaccine had demonstrated low effectiveness against the main strain of flu that had circulated this past winter. Dr. Michael Skinner of Imperial College London, said in response, “Trying to predict which seasonal flu vaccine to produce each year must be a bit like a Jack Bauer car chase in Los Angeles…bound to prove somewhat hit & miss.” 

A similar miss occurred in 2004, when the United States suspended The Chiron Corporation’s shipment of 48 million doses of vaccine, citing problems at the company’s Liverpool, England, manufacturing plant.

Read More

Topics: Brand Insights, Market Analysis, Pharma, Scenario Analysis, Healthcare, Life Sciences, Merger and Acquisition

Fuld + Company Blog

The material on this page draws on the research and experience of Fuld + Company thought leaders, consultants and others. Learn more about our expertise here.

Recent Posts

Request for Information

If you'd like someone at Fuld to contact you regarding your strategic competitive challenges, fill out the form below.